20 May 2013
Keywords: orphan, status, santhera, omigapil, swiss, specialty, drug
Article | 01 September 2008
Swiss specialty drug firm Santhera Pharmaceuticals that the US Food and Drug Administration has granted orphan drug designation to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
17 May 2013
© 2013 thepharmaletter.com